VIOL Medical Co., Ltd.

335890 KRX Technology Technology
KRX
₩10,340.00
-98.98%
Delayed · cached 15 min
Fair Value Analysis →

Strengths

  • Low debt: debt-to-equity of 0.14.
  • Return on equity is healthy at 29.5%.
  • Return on capital employed is healthy at 33%.
  • Net profit margin is strong at 36.9%.
  • Current assets comfortably cover current liabilities (current ratio 7.69).
  • Pays a dividend (yield about 3.1%).

!Watch-points

No notable watch-points flagged by the automated checks.

These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.

Forensic Checks

Altman Z-ScoreGrey zone
2.62

This middle range was less conclusive in Altman’s study — neither clearly safe nor clearly distressed.

Computed without the market-value term.

Piotroski F-ScoreWeak
3 / 4

The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.

Based on 4 of the 9 signals — the rest need data not available for this stock.

These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.

Key Ratios

Current Price₩ 10,340.00
High / Low₩ 27,500.00 / 6,380.00
Book Value₩ 669.78
Dividend Yield3.10%
ROCE32.97%
ROE29.47%
Debt to Equity0.14
Current Ratio7.69
EPS₩ 198.00
PAT Margin36.88%
Educational data only. Not a recommendation to buy, sell or hold any security.